|
TIFA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.023000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.711590E-01 |
| Normal-vs-Stage2 |
1.129770E-01 |
| Normal-vs-Stage3 |
9.080800E-01 |
| Normal-vs-Stage4 |
3.607000E-01 |
| Stage1-vs-Stage2 |
4.461600E-01 |
| Stage1-vs-Stage3 |
2.441600E-02 |
| Stage1-vs-Stage4 |
9.169400E-01 |
| Stage2-vs-Stage3 |
3.612400E-02 |
| Stage2-vs-Stage4 |
5.269800E-01 |
| Stage3-vs-Stage4 |
2.318200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.300600E-01 |
| Normal-vs-AfricanAmerican |
2.947800E-01 |
| Normal-vs-Asian |
5.131800E-01 |
| Caucasian-vs-AfricanAmerican |
4.588500E-04 |
| Caucasian-vs-Asian |
8.418400E-01 |
| AfricanAmerican-vs-Asian |
9.898000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.596210E-01 |
| Normal-vs-Female |
5.167600E-01 |
| Male-vs-Female |
2.146000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.849800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.901440E-01 |
| Normal-vs-Age(61-80Yrs) |
1.896580E-01 |
| Normal-vs-Age(81-100Yrs) |
6.548400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.687600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.751900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.748800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.339000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.784200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.642000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.022400E-01 |
| Normal-vs-Grade 2 |
1.259990E-01 |
| Normal-vs-Grade 3 |
3.550600E-01 |
| Normal-vs-Grade 4 |
6.888200E-01 |
| Grade 1-vs-Grade 2 |
9.230600E-01 |
| Grade 1-vs-Grade 3 |
4.783000E-01 |
| Grade 1-vs-Grade 4 |
4.595000E-01 |
| Grade 2-vs-Grade 3 |
3.006000E-01 |
| Grade 2-vs-Grade 4 |
4.205400E-01 |
| Grade 3-vs-Grade 4 |
7.675600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.458400E-03 |
| Normal-vs-ccB subtype |
6.582800E-01 |
| ccA subtype-vs-ccB subtype |
2.4024999989436E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.523200E-01 |
| Normal-vs-N1 |
3.211200E-01 |
| N0-vs-N1 |
4.468600E-01 |
|
|
